Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Omega Therapeutics revenue
Omega Therapeutics's revenue is $3.1 million.
What is Omega Therapeutics's revenue?
- Omega Therapeutics's revenue growth from 2021 to 2023 is 2,048.61%.
- Omega Therapeutics has 80 employees, and the revenue per employee ratio is $38,675.
- Omega Therapeutics's peak quarterly revenue was $2.6M in 2024(q3).
- Omega Therapeutics peak revenue was $3.1M in 2023.
- Omega Therapeutics annual revenue for 2022 was 2.1M, 1,339.58% growth from 2021.
- Omega Therapeutics annual revenue for 2023 was 3.1M, 49.25% growth from 2022.
On this page
Zippi applies for you, and finds you a job.
Omega Therapeutics historical revenue
Omega Therapeutics's peak revenue was $3.1M in 2023. The peak quarterly revenue was $2.6M in 2024(q3).
Omega Therapeutics's revenue increased from $144.0k in 2021 to $3.1M currently. That's a 2,048.61% change in annual revenue.
Omega Therapeutics annual revenue
Omega Therapeutics annual revenue over time
| Fiscal year / year | Omega Therapeutics revenue |
|---|---|
| 2021 | $144,000 |
| 2022 | $2.1M |
| 2023 | $3.1M |
Omega Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Omega Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2021 | - | - | - | $143,935 |
| 2022 | $268,000 | $476,000 | $595,000 | $735,000 |
| 2023 | $516,000 | $759,000 | $831,000 | $989,000 |
| 2024 | $2.4M | $2.1M | $2.6M | - |
Omega Therapeutics jobs nearby
Do you work at Omega Therapeutics?
Did Omega Therapeutics meet its revenue projections?
Omega Therapeutics financing
Omega Therapeutics received early financing of $28.4M on 2017-08-01.
| Series | Round size | Date |
|---|---|---|
| Series A | $28.4M | 08/2017 |
| Series B | $85M | 07/2020 |
| Series C | $126M | 03/2021 |
Omega Therapeutics investors
| Investors | Security type |
|---|---|
| Flagship Ventures | Series A |
| HarbourVest Partners | Series B |
| Flagship Ventures | Series B |
| Logos Capital | Series C |
| LifeSci Venture Partners | Series C |
| Point72 Asset Management | Series C |
| Mirae Asset Capital | Series C |
| Invus | Series C |
| Cowen and Company | Series C |
| Fmr | Series C |
| Flagship Ventures | Series C |
| BlackRock, Inc. | Series C |
Omega Therapeutics competitors
Omega Therapeutics's top competitor, Arvinas Inc., earned an annual revenue of $263.4M.
Omega Therapeutics's smallest competitor is CSRHub with revenue of $460.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Spring Bank Pharmaceuticals | - | $64.9M | 84 | - |
| Lumena Pharmaceuticals | - | $1.3M | 17 | - |
| eFFECTOR Therapeutics | - | $42.0M | 24 | - |
| Oncternal Therapeutics | - | $785,000 | 13 | - |
| Aquestive Therapeutics | - | $57.6M | 100 | - |
| Cerecor | - | $6.7M | 32 | - |
| Arvinas Inc. | - | $263.4M | 83 | - |
| Cortexyme | - | $167.0M | 37 | - |
| Cara Therapeutics | - | $7.1M | 84 | - |
| Outlook Therapeutics | - | $8.1M | 10 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Omega Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Omega Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Omega Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Omega Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Omega Therapeutics. The data presented on this page does not represent the view of Omega Therapeutics and its employees or that of Zippia.
Omega Therapeutics may also be known as or be related to OMEGA THERAPEUTICS, INC., Omega Therapeutics, Omega Therapeutics Inc and Omega Therapeutics, Inc.